États-Unis · Plateformes & données · MarketBeat

Gossamer Bio (NASDAQ:GOSS) Stock Gets Price Target Reduction from Wedbush

Publié par MarketBeat · États-Unis il y a 16 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Wedbush cut their price objective on shares of Gossamer Bio from $80.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Gossamer Bio (NASDAQ:GOSS) Stock Gets Price Target Reduction from Wedbush

Résumé détaillé

À lire aussi

Chinese university on US blacklist bought Nvidia H200 AI chips: report

3 Superior Growth Stocks That Can Outperform for the Next 10 Years

My friend hates her job but shuts down when I give her advice. How can I help her?

Best Stocks Under $5

Alibaba announces plans to list T-Head, its Nvidia chip rival

Market Shrugs Off Rates Again as CoreWeave Eases the Capital Crunch

Gossamer Bio (NASDAQ:GOSS) Stock Gets Price Target Reduction from Wedbush

Résumé détaillé

Partager

À lire aussi

Chinese university on US blacklist bought Nvidia H200 AI chips: report

3 Superior Growth Stocks That Can Outperform for the Next 10 Years

My friend hates her job but shuts down when I give her advice. How can I help her?

Best Stocks Under $5

Alibaba announces plans to list T-Head, its Nvidia chip rival

Market Shrugs Off Rates Again as CoreWeave Eases the Capital Crunch